Email Alert | RSS

Chinese Journal of Antituberculosis ›› 2024, Vol. 46 ›› Issue (1): 119-123.doi: 10.19982/j.issn.1000-6621.20230300

• Review Articles • Previous Articles    

Research progress of GeneXpert MTB/RIF stool test in children tuberculosis

Li Xiaoying1, Fang Yulian2, Ning Jing1, Xu Yongsheng1()   

  1. 1Department of Respiratory, Tianjin Children’s Hospital (Children’s Hospital of Tianjin University), Tianjin 300134, China
    2Tianjin Pediatric Research Institute, Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Tianjin Children’s Hospital (Children’s Hospital of Tianjin University), Tianjin 300134, China
  • Received:2023-08-21 Online:2024-01-10 Published:2024-01-04
  • Contact: Xu Yongsheng, Email: xxyyss@126.com
  • Supported by:
    Public Health and Technology Project of Tianjin(TJWJ2021QN049);Program of Tianjin Science and Technology Plan(20JCZXJC00170);Program of Tianjin Science and Technology Plan(21JCYBJC00430)

Abstract:

Difficulties in obtaining specimens and low positive rates in pathogen diagnosis exist in pediatric active tuberculosis. Xpert, a real-time fluorescence quantitative nucleic acid amplification test for Mycobacterium tuberculosis (MTB) and rifampin resistance, is rapid and provides a reliable basis for the diagnosis of tuberculosis with high sensitivity and specificity. Currently, this method has been widely used for sputum or gastric fluid test, and the application value of fecal samples in pulmonary tuberculosis diagnosis has been almost affirmed, while further research is still needed for extra-pulmonary tuberculosis. This article reviewed the use of this method for detecting MTB in fecal samples of children with tuberculosis, aiming to provide reference for the clinical application of Xpert in fecal testing for children.

Key words: Tuberculosis, Feces, Molecular diagnostic techniques, Child

CLC Number: